Bulletin
Investor Alert

New York Markets Open in:

press release

April 19, 2022, 6:30 a.m. EDT

Sage Therapeutics to Report First Quarter 2022 Financial Results on Tuesday, May 3, 2022

CAMBRIDGE, Mass., (BUSINESS WIRE) -- Sage Therapeutics, Inc. /zigman2/quotes/200179567/composite SAGE +0.91% , a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, May 3, 2022 at 8:00 a.m. ET to announce first quarter 2022 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com . A replay of the webcast will be available approximately two hours after the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit. www.sagerx.com .

View source version on businesswire.com: https://www.businesswire.com/news/home/20220413005785/en/

SOURCE: Sage Therapeutics, Inc.

Investor
Helen Rubinstein
315-382-3979
helen.rubinstein@sagerx.com Media Becky Kern
914-772-2310
becky.kern@sagerx.com

COMTEX_405920727/2456/2022-04-19T06:30:03

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

Copyright Business Wire 2022

/zigman2/quotes/200179567/composite
US : U.S.: Nasdaq
$ 37.79
+0.34 +0.91%
Volume: 123,095
Nov. 25, 2022 1:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$2.25 billion
Rev. per Employee
$13,724
loading...

Comtex

Partner Center

Link to MarketWatch's Slice.